Navigation Links
Gene therapy a step closer to mass production
Date:6/24/2010

ges. The immune system of the person receiving treatment often interferes with viral activity; and viruses can have unpredictable mutagenic side-effects. Also large-scale production of viral vectors is problematic.

A wide range of chemical agents are already known to be able to form a complex of 1,4-DHP with DNA and deliver it into the recipient's cells. These agents are much easier to produce on a large scale than viruses and do not usually cause an immune response. However they are not so effective at introducing the DNA as the viral carriers.

Seeking the best of both worlds

The challenge facing the partners in the EUREKA project was to combine the effectiveness of the viral vectors with the production advantages and lack of immune response shown by chemical agents. Scientists at the Latvian Institute of Organic Synthesis and the University of Kuopio in Finland had discovered new groups of possible DNA transfer agents: 1,4-DHP derivatives. These compounds were found to be more effective in gene transfer than two widely-used standard gene delivery agents (known as DOTAP and PEI 25) and the discovery was covered by a patent. This finding offered the exciting prospect of better efficiency from a non-viral carrier.

Professor Arto Urtti of Helsinki University (formerly from Kuopio) explains: "When these compounds are in solution and DNA is added, they bind together. The large, loose DNA molecule collapses and tiny particles of about 10-50nm in diameter are formed, composed of both DNA and carrier. When you present this to the cells, the nanoparticles bind to the cell surface, which folds inwards to form a vesicle within the cell. The particles then escape from the vesicle, releasing the DNA."

Researchers at Helsinki University found that out of all the compounds tested, the most effective were those which succeeded in transferring DNA into the nucleus. The mechanism by which the DNA enters the nucleus is not yet c
'/>"/>

Contact: Piotr Pogorzelski
piotr.pogorzelski@eurekanetwork.org
322-777-0979
EUREKA
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. UF oncologists fight leukemia with two-pronged therapy, clinical trials planned
2. McGill team discovers a piece of the puzzle for individualized cancer therapy via gene silencing
3. Making personalized lung cancer therapy a reality in Europe
4. Meta-analysis: Radiotherapy variants improve survival in non-metastatic lung cancer
5. 4-D software helps adjust for breathing when treating lung cancer with radiotherapy
6. Tool allows precise targeting of radiotherapy for cancer radiation therapy
7. Gene therapy sets stage for new treatments for inherited blindness, Penn veterinary researchers say
8. Smoking during radiation therapy for head and neck cancers linked to poorer outcomes
9. JDRF partners with LCT to test encapsulated cell replacement therapy for the treatment of diabetes
10. Concord Medical Enters Agreement to Acquire Four Radiotherapy and Diagnostic Imaging Centers in Hebei Province
11. Lengthening time a drug remains bound to a target may lead to improving diagnostics, therapy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gene therapy a step closer to mass production
(Date:12/17/2014)... NEW YORK , Dec. 15, 2014  HITLAB SM ... Practices (GCP) audit to confirm its adherence to current ... enables HITLAB to conduct regulated smart device and smart ... safety and research quality. "HITLAB is determined ...
(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... the "Global Facial Recognition Market 2015-2019" report ... Facial recognition is a technology used ... the overall facial feature of a person such as ...
(Date:12/11/2014)... Dec. 10, 2014  Data Sciences International (DSI), the ... a new series of digital telemetry implants to ... M series, part of the PhysioTel™ Digital platform, ... possible physiologic data when incorporating functional endpoints into ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3New telemetry implants expected to change how large animal toxicology studies are conducted 2
... integral part of U.S. agriculture. Nearly $200 million of ... the facilities play a vital role in producing seeds ... healthy can translate to increased revenue for producers. ... and Christopher R. Little of Kansas State University (Manhattan) ...
... Liverpool will lead a 4 million study to analyse the ... how living cells function. Many proteins that have ... and signalling proteins, were first discovered through the study of ... have been originally isolated on the skins of grapes. ...
... WI, February 16, 2009 -- Grasslands in the Conservation ... increasingly converted to growing bioenergy grain crops. Questions abound ... during the CRP program by perennial grasses if the ... potential effectiveness of no-till production systems to conserve the ...
Cached Biology News:Detecting disease in greenhouse plants 2Scientists study full protein content of 'baker's yeast' 2Will large amounts of soil carbon be released if grasslands are converted to energy crops? 2
(Date:1/22/2015)... , Jan. 22, 2015   GenoSpace , a precision medicine ... to enable the broad use of genomic, imaging and other ... appointment of Michelle Munson , CEO of Aspera, an ... Logo - http://photos.prnewswire.com/prnh/20150122/170713 "We ...
(Date:12/24/2014)... 2014  United Therapeutics Corporation (NASDAQ: UTHR ) ... ) has submitted a pre-market approval application to the ... of Medtronic,s SynchroMed ® II implantable drug infusion ... United Therapeutics, Remodulin ® (treprostinil) Injection delivered intravenously ...
(Date:12/24/2014)... Wash. , Dec. 24, 2014   BioLife Solutions , ... and marketer of proprietary clinical grade hypothermic storage ... shipping products for cells and tissues  ("BioLife" or the ... Meeting of Stockholders on May 4, 2015 (the "Annual Meeting"). ...
(Date:12/24/2014)... Boston, MA (PRWEB) December 23, 2014 Earlier ... James L. Sherley, director of the Adult Stem Cell Technology ... overlooked and under appreciated unique property of adult tissue stem ... Misunderstood in the Past, Important for the Future,” embodied the ...
Breaking Biology Technology:GenoSpace Expands Board with Appointment of Michelle Munson 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4BioLife Solutions Sets Date for Annual Meeting of Stockholders 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4
... Real-Time Location System provider for healthcare, is pleased to ... Real-Time Location System . The new messaging better captures ... – , Industry-Leading Accuracy , ... Applications Easy Installation and Maintenance ...
... been mysteriously falling for at least five years in the ... (CCD) is still largely unknown. In a report ... , researchers report that a widely used in-hive medication may ... and that this interaction may be at least partially responsible ...
... and SHENZHEN, China, Nov. 2, 2011 Advanced BioMedical ... internal fixation devices, is pleased to announce the formation ... comprised of three distinguished physicians and scientists. The combined ... critical scientific and strategic input as the Company continues ...
Cached Biology Technology:CenTrak, a Leading Real-Time Location System Provider, Unveils New Branding 2Advanced BioMedical Technologies Inc. Announces Formation of Scientific Advisory Board 2Advanced BioMedical Technologies Inc. Announces Formation of Scientific Advisory Board 3Advanced BioMedical Technologies Inc. Announces Formation of Scientific Advisory Board 4Advanced BioMedical Technologies Inc. Announces Formation of Scientific Advisory Board 5Advanced BioMedical Technologies Inc. Announces Formation of Scientific Advisory Board 6Advanced BioMedical Technologies Inc. Announces Formation of Scientific Advisory Board 7
...
ANTI DIPHTH TOX A SU...
... Bullseye Red Taq DNA Polymerase is a ... high activity in primer extension and other ... red dye which provides easy and quick ... added and allows confirmation of complete mixing. ...
... is a new technology for sensitive ... small amounts of DNA (5). This ... to modify the DNA, followed by ... to distinguish methylated from unmethylated DNA. ...
Biology Products: